We are live on ! Find out more
CTOR

Citius Oncology
CTOR

14 hedge funds and large institutions have $8.83M invested in Citius Oncology in 2026 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 1

29% more capital invested

Capital invested by funds: $6.86M → $8.83M (+$1.97M)

8.05% more ownership

Funds ownership: 8.09% → 16.14% (+8%)

22% less funds holding

Funds holding: 18 → 14 (-4)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
14
Holders Change
-4
Holders Change %
-22.22%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
1
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$3.85M
2
AC
Armistice Capital
New York
+$3.62M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$44.9K
4
BlackRock
BlackRock
New York
+$25.2K
5
IA
IFP Advisors
Florida
+$20.1K

Top Sellers

Rank Fund Capital Flow
1
OAC
OMERS Administration Corp
Ontario, Canada
-$105K
2
XT
XTX Topco
Cayman Islands
-$74K
3
Two Sigma Investments
Two Sigma Investments
New York
-$23.5K
4
TSS
Two Sigma Securities
New York
-$13.4K
5
VCM
Versant Capital Management
Arizona
-$1.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$5.7M +$3.62M +3,604,775 +65%
Bank of America
2
Bank of America
North Carolina
$2.37M +$3.85M +3,834,946 +1,792,031%
VCM
3
Vanguard Capital Management
Pennsylvania
$332K +$537K +534,824 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$164K +$44.9K +44,686 +20%
VFT
5
Vanguard Fiduciary Trust
Pennsylvania
$75.6K +$122K +121,910 New
IA
6
IFP Advisors
Florida
$66.6K +$20.1K +20,000 +23%
BlackRock
7
BlackRock
New York
$29.4K +$25.2K +25,110 +112%
Northern Trust
8
Northern Trust
Illinois
$28.4K – – –
State Street
9
State Street
Massachusetts
$26.6K – – –
UBS Group
10
UBS Group
Switzerland
$22.8K +$15.4K +15,376 +72%
AWA
11
Arkadios Wealth Advisors
Georgia
$7.23K – – –
Osaic Holdings
12
Osaic Holdings
Arizona
$6.28K -$1.31K -1,300 -11%
CIAM
13
Caitong International Asset Management
Hong Kong
$1 +$1 +1 New
OAC
14
OMERS Administration Corp
Ontario, Canada
– -$105K -104,500 Closed
XT
15
XTX Topco
Cayman Islands
– -$74K -73,992 Closed
Two Sigma Investments
16
Two Sigma Investments
New York
– -$23.5K -23,515 Closed
TSS
17
Two Sigma Securities
New York
– -$13.4K -13,360 Closed
VCM
18
Versant Capital Management
Arizona
– -$1.5K -1,500 Closed
FFA
19
Farther Finance Advisors
California
– -$3 -3 Closed
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
– +$164 +163 +709%

CTOR Hedge Fund Activity: Q1 2026 in Review

14 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Citius Oncology (CTOR) for Q1 2026, worth a combined $8.83M — up 29% from $6.86M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of CTOR and 3 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 7 added.

The largest buyer was Bank of America, adding an estimated $3.85M. The largest seller was OMERS Administration Corp, exiting entirely with an estimated $105K sold.

  • 14 institutional investors held Citius Oncology (CTOR) as of Q1 2026, down from 18 in Q4 2025.
  • Funds reported $8.83M of Citius Oncology stock for Q1 2026, up 29% quarter-over-quarter.
  • 3 funds opened new Citius Oncology positions in Q1 2026 and 6 closed out, a net change of -3 holders.
  • The largest Citius Oncology buyer in Q1 2026 was Bank of America, an estimated $3.85M added.
  • The largest Citius Oncology seller in Q1 2026 was OMERS Administration Corp, an estimated $105K sold.

Based on aggregated 13F filings for Q1 2026.